Fate Therapeutics FATE
NASDAQ FATE
$2.38 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Operating Expenses (2012 - 2026)

Updated

Fate Therapeutics' Operating Expenses came in at $33.22 million for Q2 2026, down 14.6% from $38.88 million a year earlier and down 3.2% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Operating Expenses (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Fate Therapeutics reported Operating Expenses of $140.08 million, down 30.3% year-over-year; for FY2025, it was $154.35 million, down 31.1% from FY2024.

  • Operating Expenses has declined in each of the last three years, with a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
  • Going back by year, Operating Expenses was $223.91 million in FY2024 (-11.9%), $254.04 million in FY2023 (-37.2%), $404.69 million in FY2022 (+48.3%) and $272.84 million in FY2021 (+71.0%).
  • The Q2 2026 figure represents the lowest quarterly Operating Expenses since Q4 2019.
  • Year-over-year, Operating Expenses has declined for six consecutive quarters, with an average decline of 15.5% over the last eight quarters.
  • The fastest year-over-year change in Operating Expenses over five years came in Q3 2021 (growth of 76.3%), and the weakest in Q4 2023 (a decline of 54.3%).
  • Business Quant data shows FATE's Operating Expenses at $34.3 million (Q1 2026), $36.09 million (Q4 2025) and $36.48 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Fate Therapeutics 277.73 Mn 277.73 Mn - 33.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.22 Mn
Mar 31, 2026 34.30 Mn
Dec 31, 2025 36.09 Mn
Sep 30, 2025 36.48 Mn
Jun 30, 2025 38.88 Mn
Mar 31, 2025 42.91 Mn
Dec 31, 2024 63.61 Mn
Sep 30, 2024 55.45 Mn
Jun 30, 2024 51.86 Mn
Mar 31, 2024 52.99 Mn
Dec 31, 2023 49.75 Mn
Sep 30, 2023 53.22 Mn
Jun 30, 2023 63.50 Mn
Mar 31, 2023 87.57 Mn
Dec 31, 2022 108.78 Mn
Sep 30, 2022 101.37 Mn
Jun 30, 2022 101.66 Mn
Mar 31, 2022 92.88 Mn
Dec 31, 2021 86.45 Mn
Sep 30, 2021 68.85 Mn
API Access

Fate Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=FATE&period=max&api_key=YOUR_API_KEY